MX9701731A - Composiciones anti-bacterianas oticas, no-irritantes, no-sensibles y no-toxicas para el oido. - Google Patents

Composiciones anti-bacterianas oticas, no-irritantes, no-sensibles y no-toxicas para el oido.

Info

Publication number
MX9701731A
MX9701731A MX9701731A MX9701731A MX9701731A MX 9701731 A MX9701731 A MX 9701731A MX 9701731 A MX9701731 A MX 9701731A MX 9701731 A MX9701731 A MX 9701731A MX 9701731 A MX9701731 A MX 9701731A
Authority
MX
Mexico
Prior art keywords
esophagus
metaplasia
probe
wall
esophageal
Prior art date
Application number
MX9701731A
Other languages
English (en)
Inventor
Shivaji Purwar
David Goldman
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MX9701731A publication Critical patent/MX9701731A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Endoscopes (AREA)

Abstract

Composiciones por introduccion preferiblemente mediante instalacion, en orejas de humanos y animales y un método para el tratamiento de otitis externa y otitis media, especialmente otorrea. Las composiciones son no toxicas, para el oído, no irritantes y no sensibles. Las composiciones son de base acuosa y contienen ciprofloxacina y opcionalmente hidrocortisona.
MX9701731A 1995-06-06 1996-06-05 Composiciones anti-bacterianas oticas, no-irritantes, no-sensibles y no-toxicas para el oido. MX9701731A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46504895A 1995-06-06 1995-06-06
PCT/US1996/008864 WO1996039146A1 (en) 1995-06-06 1996-06-05 Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions

Publications (1)

Publication Number Publication Date
MX9701731A true MX9701731A (es) 1997-10-31

Family

ID=23846298

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701731A MX9701731A (es) 1995-06-06 1996-06-05 Composiciones anti-bacterianas oticas, no-irritantes, no-sensibles y no-toxicas para el oido.

Country Status (17)

Country Link
US (1) US5965549A (es)
EP (1) EP0782448B1 (es)
CN (1) CN1137685C (es)
AT (1) ATE214931T1 (es)
AU (1) AU708540B2 (es)
CA (1) CA2199294C (es)
DE (1) DE69620136T2 (es)
DK (1) DK0782448T3 (es)
ES (1) ES2173287T3 (es)
HK (1) HK1002552A1 (es)
IL (1) IL120317A (es)
MX (1) MX9701731A (es)
NZ (1) NZ309624A (es)
PT (1) PT782448E (es)
TW (1) TW464499B (es)
WO (1) WO1996039146A1 (es)
ZA (1) ZA964653B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
AR020661A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
WO2000018404A1 (en) * 1998-09-30 2000-04-06 Alcon Laboratories, Inc. Antibiotic compositions for treatment of the eye, ear and nose
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6500360B2 (en) * 1999-06-18 2002-12-31 Bernard Bendiner Sorbic acid and/or its derivatives, such as potassium sorbate, as a preventative for rust, corrosion and scale on metal surfaces
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US7064132B2 (en) * 1999-11-28 2006-06-20 Scientific Development And Research, Inc. Composition and method for treatment of otitis external
ES2160090B1 (es) * 2000-03-16 2002-07-01 Vita Invest Sa Composiciones acuosas de ciprofloxacino, contenidas en envases monodosis y su utilizacion.
WO2002007704A2 (en) * 2000-07-26 2002-01-31 Alcon Universal Ltd. Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone
MXPA03002342A (es) 2000-09-25 2004-10-15 Bayer Healthcare Llc Combinaciones microbianas opticas para el tratamiento de animales con la membrana timpanica rota.
MXPA04002576A (es) 2001-09-21 2004-06-18 Alcon Inc Metodo para tratar infecciones del oido medio.
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US20040101506A1 (en) * 2002-11-25 2004-05-27 Fust Charles A. Composition for the prevention and treatment of inflammation of the ear
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20050009931A1 (en) * 2003-03-20 2005-01-13 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20050004098A1 (en) * 2003-03-20 2005-01-06 Britten Nancy Jean Dispersible formulation of an anti-inflammatory agent
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
DK1608407T3 (da) * 2003-03-20 2006-12-04 Pharmacia Corp Dispergébar formulering af et antiinflammatorisk middel
AU2004258746A1 (en) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
CN1829510A (zh) * 2003-07-31 2006-09-06 法马西亚和厄普乔恩公司 抗炎剂的可分散性制剂
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
CA2548892C (en) * 2003-12-12 2015-10-27 Eran Eilat Compositions for treatment of ear disorders and methods of use thereof
US20060019987A1 (en) * 2004-07-23 2006-01-26 Fust Charles A Methods and compositions for inhibiting, destroying, and/or inactivating viruses
PL1962805T3 (pl) 2005-12-08 2017-01-31 Insmed Incorporated Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
UA111147C2 (uk) * 2009-11-11 2016-04-11 Байєр Б.В. Способи та композиції для лікування або профілактики зовнішнього отиту
DK2366408T3 (da) 2010-03-01 2012-10-22 Salvat Lab Sa Vandige, klare opløsninger af fluocinolonacetonid til behandling af inflammation i øret
HU227743B1 (en) * 2011-07-22 2012-02-28 Debreceni Egyetem Eardrop composition and process for producing this
BR112014013564A2 (pt) * 2011-12-09 2017-06-13 Lupin Ltd composição farmacêutica tópica destinada à aplicação ao olho, ouvido ou nariz
RU2018135921A (ru) 2012-11-29 2019-02-05 Инсмед Инкорпорейтед Стабилизированные составы ванкомицина
ES2755941T3 (es) 2014-05-15 2020-04-24 Insmed Inc Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas
US9393243B1 (en) 2015-07-14 2016-07-19 Nilesh Parikh Topical Ciprofloxacin compositions
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025620A (en) * 1975-10-22 1977-05-24 Leo Pharmaceutical Products Ltd., A/S Treatment of canine otitis and composition therefor
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3471639D1 (en) * 1983-03-31 1988-07-07 Payne Packaging Ltd Improvements in or relating to tapes
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3704907A1 (de) * 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
US5061729A (en) * 1988-06-08 1991-10-29 Biogal Gyogyszergyar Pharmaceutical composition and process for preparing the same
US5271939A (en) * 1988-10-03 1993-12-21 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5260073A (en) * 1990-05-21 1993-11-09 Norwich Eaton Pharmaceuticals, Inc. Use of phenylpropanolamine as a mucus secretogogue in the upper airways
WO1994010976A1 (en) * 1992-11-16 1994-05-26 Ciba Vision Ag, Hettlingen Polyvinyl alcohol/borate ophthalmic drug delivery system
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
ES2088742B1 (es) * 1994-06-29 1997-03-16 Salvat Lab Sa Composicion antibiotica de aplicacion otica.

Also Published As

Publication number Publication date
IL120317A (en) 2000-08-13
DK0782448T3 (da) 2002-07-08
IL120317A0 (en) 1998-06-15
DE69620136D1 (de) 2002-05-02
AU5984096A (en) 1996-12-24
TW464499B (en) 2001-11-21
US5965549A (en) 1999-10-12
EP0782448B1 (en) 2002-03-27
EP0782448A1 (en) 1997-07-09
ES2173287T3 (es) 2002-10-16
WO1996039146A1 (en) 1996-12-12
DE69620136T2 (de) 2002-08-01
CN1160999A (zh) 1997-10-01
CA2199294A1 (en) 1996-12-12
AU708540B2 (en) 1999-08-05
EP0782448A4 (en) 1998-05-20
PT782448E (pt) 2002-07-31
ZA964653B (en) 1996-12-12
NZ309624A (en) 1999-04-29
CA2199294C (en) 2000-09-19
CN1137685C (zh) 2004-02-11
HK1002552A1 (en) 1998-09-04
ATE214931T1 (de) 2002-04-15

Similar Documents

Publication Publication Date Title
MX9701731A (es) Composiciones anti-bacterianas oticas, no-irritantes, no-sensibles y no-toxicas para el oido.
CA2195075A1 (en) Method and Apparatus for Detecting Barrett's Metaplasia of the Esophagus
US6516216B1 (en) Circumferential transillumination of anatomic junctions using light energy
US5649546A (en) Metal detector for the localization of a metallic foreign body penetrated or implanted into a human or animal body
EP2412311B1 (en) Feeding tube position confirmation device
US20070299425A1 (en) Infrared assisted monitoring of a catheter
NO943213L (no) Apparat for endoskop- eller gastroskop-undersökelse av pasienter
ATE221338T1 (de) Ynzeige von thermischen unstetigkeiten an gefässwänden
GB9519194D0 (en) Anorectal angle measurement
EP0856278A3 (en) Device and method for locating inflamed plaque in an artery
HK1032520A1 (en) Apparatus for detecting electro-magnetic reflection from biological tissue.
DK0552050T3 (da) Endoskopisk kirurgisk system med sensororganer
NO914635D0 (no) Kopling som baerer en foeler for et kateter
SG55292G (en) Disposable catheter insertion apparatus
CA2204844A1 (en) An infrared system for visualizing various body members
FR2649604B1 (fr) Instrument ancillaire chirurgical de reperage de l'entree et de la direction du tunnel d'insertion femorale d'un neo-ligament dans des conditions d'isometrie totale
EP0862897A3 (de) Verfahren und Vorrichtung zum Ermitteln von Karies an Zähnen
WO1995026673A3 (en) Apparatus and method for imaging diseased tissue using integrated autofluorescence
WO1999030485A3 (en) X-ray examination apparatus
HK1006943A1 (en) Method of measuring blood pressure and automatic sphygmomanometer for implementing said method
EP0392026A4 (en) Tube used for lining of conduit
FR2737124B1 (fr) Dispositif de detection du retrait accidentel d'un tube enfonce dans une cavite ou un conduit corporel d'un patient
CA2324331A1 (en) Illuminated suction tool with a disposable tip
GB2311854A9 (en) Instrument for optical measurement of living body
DE69212559D1 (de) Automatische Manschette zur Blutdruckmessung